Masaya Pharmaceuticals: Making Its Mark In Pharmaceutical Industry In Eastern India

Debashis Haldar , Founder & Director

Debashis Haldar

Founder & Director

India's pharmaceutical business is pertinent in the global pharmaceutical industry. India ranks third globally in terms of output volume and fourteenth globally in terms of valuation. With a 20 percent share of the global market, the nation is the world's largest producer of generic medications and is the premier vaccine developer. India has a robust network of more than 10,500 manufacturing facilities, more than 3,000 pharmaceutical companies, and the most US-FDA approved pharmaceutical operations and qualified resource pool outside of the US. Over 50 percent of the world's demand for various vaccines is met by the Indian pharmaceutical industry, as is 40 percent of the US market for generic drugs and 25 percent of the UK market overall. The nation also possesses a sizable pool of scientists and engineers that might propel the sector forward and to new heights. Currently, Indian pharmaceutical companies provide more than 80 percent of the make this one word medications needed to treat AIDS (Acquired Immune Deficiency Syndrome) around the world.

Among the various market leaders, Masaya Pharmaceuticals, based in Kolkata, West Bengal, is a pioneering pharmaceuticals company catering to the unmet needs of millions of people in India. Constantly upgrading their facilities and technology used in formulating the highest quality healthcare products, Masaya has adopted Good Manufacturing Practices. Belonging to a crucial industry like Pharma, Masaya has established strict Quality control measures. Further, the marketing and digital team, and the authorized distributors are strategically located and supported by a Field Force. All of these measures allow the company to function smoothly and make its products available to all the people easily. Masaya understands the lack of innovation in the medical industry and the need to establish the same through concentrated efforts, the company aspires to achieve innovation in manufacturing of products which the nation needs right now.

Fulfilling Market Expectations Expertly

Masaya is a proponent of the importance of exceptional and distinctive products. Their dedication to excellence and client satisfaction is demonstrated by their quality management system. Masaya offers reliable and high-quality medical supplies and services. Being an Indian enterprise, Masaya takes satisfaction in knowing what's ideal for India's healthcare sector. “At MASAYA, our mission acts as an underlying principle to whatever we do. We will work 'Together for Happiness', our values and expectations guide our everyday actions and decision-making", says Debashis Haldar, Founder of Masaya Pharmaceuticals. The business aims to be an international company with cutting-edge and state-of-the-art manufacturing capabilities and facilities, high-quality products and potency, marketing capabilities in important therapeutic areas through product differentiation and creativity, moral sales and distribution practices, and successful branding and promotional strategies.

Through well implemented technologies and policies, Masaya is leveraging its potential to achieve its goals. In terms of services, their Quality Management System is designed to continually provide their customers as well as the medical community with new health care products of the highest quality that give superior patient care, Masaya will prioritize research and development, embrace the most recent technology, and implement CGMPs. Masaya’s products are manufactured in GMP, ISO and HACCP compliant plants. The workforce at Masaya is motivated to provide trustworthy, high-quality healthcare products and services while offering exceptional and differentiating value of the products. Masaya Pharmaceuticals' dedication to producing high-quality goods and ensuring client satisfaction is clearly demonstrated through its quality assurance system. Additionally, the team takes satisfaction in knowing what the Indian healthcare business needs and providing it. The team has expertise working with the Indian market scenario and leverages this knowledge in assuring top-notch product quality.

When it comes to product range, Masaya Pharmaceuticals’ range of products currently consists of antifungal, anti-allergens, complete moisturizing solutions, and Demelanizing agents to get rid of pigmentation of all types. These products are suitable for all skin-types which makes them unique and innovative. Masaya is continually striving to increase its product range to include more innovative products to cater to the needs of the urban, semi-urban and rural regions of India. Its unparalleled research and development efforts have made it possible for the team to come up with unique formulations suitable for the Indian skin.

What differentiates masaya from its competitors is that masaya upholds its core values of putting doctors first, exhibiting compassion for others, operating honorably, and conducting business openly

Debashis Haldar , Founder & Director

What differentiates Masaya from its competitors is that Masaya upholds its core values of putting doctors first, exhibiting compassion for others, operating honorably, and conducting business openly. We take great pride in our dedication to making a difference in people's lives by offering them distinctive and unique Brands. “We have taken the pledge of spreading miles of smiles in India through our innovative products, quality and customer satisfaction", adds Debashis Haldar. As a result of these effective measures, Masaya, despite beginning in just 3 territories, has now expanded to reach 80 percent of its targeted customers in the East in a mere 12 months. Through the combined efforts of various stakeholders, the company has been able to grow 1400 percent in the short span and flourish effortlessly, and is now striving to create its presence throughout India by March 2023.

Future Plans

Future projections predict that the pharmaceuticals business will expand steadily as a result of growing awareness about personal health, and rapid advancements in the medical domain. “We do what is right for our customers, employees, communities and ourselves. We value teamwork, working together to achieve common goals is the foundation of our success", further adds, Debashis Haldar. Through its solid market connections, the organization is well-positioned to comprehend the shifting needs of the market. Masaya therefore intends to continue its geographic expansion, starting with Nepal, Bangladesh, Bhutan, Vietnam, and Cambodia. The company is also putting robust systems and processes in place, assembling a digital marketing team, and automating distribution. Capability building of Field force and setting up strong processes and systems is another area of focus for Masaya.

The organization is eager to work with partners in a variety of industries, such as marketing and manufacturing. Masaya intends to choose third-party manufacture on a P2P or Loan License basis for its cutting-edge products and is interested in partnering with businesses possessing innovative formulas and product portfolios for marketing. In the field of Manufacturing, Masaya has set its sights on partnering with companies that have WHO GMP manufacturing facilities while in the field of marketing it is focusing on acquisition or forming tie-ups with third-party marketing vendors with expertise in the healthcare sector. Additionally, the company is also expanding across verticals and is actively recruiting suitable individuals for various roles.

Debashis Haldar, Founder & Director

He is a success-driven professional with 32 years of experience in lead­ing activities related to Brand De­velopment/Management, Business Expansion, P&L Management, Sales & Marketing, Team Management & Leadership. Having excellence in conceptualizing and executing in­novative promotions to enhance brand visibility and conduct fea­sibility/profitability analysis in coordination with the marketing team and external agencies. Skilled in maximizing revenue opportu­nities by achieving the set target through effective forecasting, pric­ing, finance management & optimal market business mix. The company is managed by Animesh Mallick (Co-Founder & Director), a success­ful, experienced and highly praised sales leader.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.